More stories
Claims Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Nikki Wilson examines Journavx, a new FDA-approved nonopioid pain medication, and its potential impact on workers' compensation as a safer alternative to opioids for acute pain management.
Workers' Comp
Article
Proposed Utilization Review Amendments to California Workers' Compensation: What to Know
Explore the proposed changes to California Workers' Compensation regulations and their potential impacts on workers, employers, and the broader system. Stay informed about how these shifts could reshape the future of compensation policies in the state.
Workers' Comp
Article
Get the Most Out of FairPay Flex: Expert Tips and Tricks
FairPay Flex, Enlyte’s specialty bill review solution, offers significant savings potential for workers' compensation medical bill review. Here are some expert tips and tricks to make the most of this powerful tool.
Workers' Comp
Article
Ask The Pharmacist: Buprenorphine’s Role in Workers’ Compensation Pain Management
Buprenorphine, a Schedule III controlled substance approved by the U.S. Food and Drug Administration (FDA), is increasingly being considered for pain management in workers' compensation cases. This partial opioid agonist offers a unique profile that balances effective pain relief with a lower risk of abuse and dependence compared to full opioid agonists.
Workers' Comp
Case Study
Overcoming Overpayment Risk With FairPay Flex
Enhance your specialty bill review workflow with Enlyte's FairPay Flex. Learn how our dedicated team can resolve disputes and streamline processes.
Auto Physical Damage
News Release
Collision Claims Increased by More Than 30% While Average Severity Plateaued for Battery Electric Vehicles Last Year
Mitchell today announced the latest release of its Plugged-In: EV Collision Insights report. This edition features an overview of the most notable annual trends in battery electric vehicle (BEV), mild hybrid electric vehicle (MHEV) and plug-in hybrid electric vehicle (PHEV) collision claims. Following a second year of record sales for new cars with electrified powertrains, claims frequency for repairable BEVs rose to 2.71% in the U.S. and 3.84% in Canada in 2024, a year-over-year increase of 38% and 34% respectively.